China Pharmaceutical University visited Jiangsu Haizhi Biotechnology to supervise research and development production and deepen school-enterprise cooperation.

2020Year8Month26In the month of , Professor Liu Jianping and Professor Sun Jianguo from China Pharmaceutical University, along with Director Zhu Xuanxuan from Jiangsu Provincial Hospital of Traditional Chinese Medicine, visited Jiangsu Haizhi Biomedical Co., Ltd. to supervise research and development production work.Both parties discussedthe current cooperation project"Research and Development of Series Functional Wet Dressings" planconductedin-depth exchanges.To continuously deepen school-enterprise cooperation and serve the Healthy China strategy, starting from the month of , Haizhi Biomedical has established deep cooperation with China Pharmaceutical University to jointly develop product formulas, optimize production processes, tackle technical challenges, closely connect cutting-edge scientific research results with market demands, and achieve a win-win situation of resource sharing and complementary advantages.

China Pharmaceutical University has a long history, and in its development over the years, it has trained a large number of outstanding pharmaceutical talents,2017Year11including nine academicians such as Xu Guojun, the founder of Chinese herbal medicine microscopic identification, and Hu Zhibi, the pioneer of traditional Chinese medicine biotechnology, earning the reputation of

"Cradle of Chinese Pharmacists" and "Huangpu Military Academy of the Pharmaceutical Industry."80Both founders of Haizhi Biomedical graduated from China Pharmaceutical University, adhering to the rigorous academic attitude of Chinese pharmacists, combining clinical medical experience, emphasizing simplified product formulas that are safe and effective, creating the most suitable repair conditions for damaged skin and mucous membranes, stimulating the skin's self-healing and regulatory abilities, and addressing skin issues from the root in a safer and more effective way.Currently, Haizhi Biomedical has² research and production bases,

² modern research and testing centers, compliant with

GMP4000mstandards,2000ma clean production area of ten thousand levels, a purification testing area of ten thousand levels, a purified water system, and irradiation sterilization, with full-process quality control.While focusing on independent research and development,it has established strategic cooperation with top domestic laboratories such as Nanjing University, Nanjing Medical University, China Pharmaceutical University, Nanjing University of Technology, and the Institute of Dermatology of the Chinese Academy of Sciences.10Professor Liu Jianping, a transdermal drug delivery expert from China Pharmaceutical University, has been appointed as the chief scientist, and Professor Gong Chunyan, director of the pharmacy department at the Institute of Dermatology of the Chinese Academy of Medical Sciences, serves as the clinical chief expert, guiding research and development work and tackling technical challenges. It has been awarded

national invention patents(with items under review),

utility model patents.7Haizhi Biomedical's brand Haibeiyan is positioned for medical beauty-level daily care, covering oralmedical beauty3care lines, all of which are products developed in cooperation with China Pharmaceutical University. Since their market launch, the products have been well-loved and trusted by consumers for their safety and effectiveness. Among them, the liquid wound dressing is comparable to Japan's Kobayashi and Germany's7SOSand has been awarded a national invention patent.

海智生物旗下品牌海倍颜，定位医美级日常护理，产品涵盖口腔/医美/护理三条线，均为海智生物与中国药科大学校的校企合作款。产品自推出市场以来，以其安全性、有效性深受消费者喜爱和信任。其中液体创口贴对标日本小林、德国SOS，荣获得国家发明专利。